Glycosaminoglycans from <i>Litopenaeus vannamei</i> Inhibit the Alzheimer’s Disease β Secretase, BACE1

Glycosaminoglycans from <i>Litopenaeus vannamei</i> Inhibit the Alzheimer’s Disease β Secretase, BACE1

Only palliative therapeutic options exist for the treatment of Alzheimer’s Disease; no new successful drug candidates have been developed in over 15 years. The widely used clinical anticoagulant heparin has been reported to exert beneficial effects through multiple pathophysiological pathways involv...

Full description

Bibliographic Details
Main Authors:	Courtney J. Mycroft-West, Anthony J. Devlin, Lynsay C. Cooper, Scott E. Guimond, Patricia Procter, Marco Guerrini, Gavin J. Miller, David G. Fernig, Edwin A. Yates, Marcelo A. Lima, Mark A. Skidmore
Format:	Article
Language:	English
Published:	MDPI AG 2021-04-01
Series:	Marine Drugs
Subjects:	Alzheimer’s disease amyloid-β BACE1 β-secretase glycosaminoglycan chondroitin sulfate
Online Access:	https://www.mdpi.com/1660-3397/19/4/203

Similar Items

A Glycosaminoglycan Extract from <i>Portunus pelagicus</i> Inhibits BACE1, the β Secretase Implicated in Alzheimer’s Disease
by: Courtney J. Mycroft-West, et al.
Published: (2019-05-01)

Scaffold Morphing and In Silico Design of Potential BACE-1 (β-Secretase) Inhibitors: A Hope for a Newer Dawn in Anti-Alzheimer Therapeutics
by: Shiveena Bhatia, et al.
Published: (2023-08-01)

Discovery of polymethoxyflavones from black ginger (Kaempferia parviflora) as potential β-secretase (BACE1) inhibitors
by: Kumju Youn, et al.
Published: (2016-01-01)

BACE-1 and γ-Secretase as Therapeutic Targets for Alzheimer’s Disease
by: Miguel A. Maia, et al.
Published: (2019-03-01)

Role of BACE1 in Alzheimer’s synaptic function
by: Brati Das, et al.
Published: (2017-08-01)

One Pot Synthesis of Micromolar BACE-1 Inhibitors Based on the Dihydropyrimidinone Scaffold and Their Thia and Imino Analogues
by: Jessica Bais, et al.
Published: (2020-09-01)

BACE1 gene deletion prevents neuron loss and memory deficits in 5XFAD APP/PS1 transgenic mice
by: Masuo Ohno, et al.
Published: (2007-04-01)

Inhibition of BACE1, the β-secretase implicated in Alzheimer’s disease, by a chondroitin sulfate extract from Sardina pilchardus
by: Courtney J Mycroft-West, et al.
Published: (2020-01-01)

The Alzheimer's β-secretase enzyme BACE1 is required for accurate axon guidance of olfactory sensory neurons and normal glomerulus formation in the olfactory bulb
by: Rajapaksha Tharinda W, et al.
Published: (2011-12-01)

Presenilin-1 interacts directly with the β-site amyloid protein precursor cleaving enzyme (BACE1)
by: Sébastien S Hébert, et al.
Published: (2003-08-01)

Overexpression of Amyloid Precursor Protein Promotes the Onset of Seborrhoeic Keratosis and is Related to Skin Ageing
by: Yuanying Li, et al.
Published: (2018-03-01)

Sex differences in circulating neuregulin1-β1 and β-secretase 1 expression in childhood-onset schizophrenia
by: Zhengrong Zhang, et al.
Published: (2020-07-01)

Dual Inhibitors of AChE and BACE-1 for Reducing Aβ in Alzheimer’s Disease: From In Silico to In Vivo
by: Noa Stern, et al.
Published: (2022-10-01)

Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models
by: Teemu Natunen, et al.
Published: (2016-01-01)

Development and Structural Modification of BACE1 Inhibitors
by: Ting Gu, et al.
Published: (2016-12-01)

4-O-galloylalbiflorin discovered from Paeonia lactiflora Pall. is a potential β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitor
by: Xiao-Long Hu, et al.
Published: (2016-12-01)

Straightforward Analysis of Sulfated Glycosaminoglycans by MALDI-TOF Mass Spectrometry from Biological Samples
by: Lynn Krüger, et al.
Published: (2022-03-01)

BACE1 Function and Inhibition: Implications of Intervention in the Amyloid Pathway of Alzheimer’s Disease Pathology
by: Gerald Koelsch
Published: (2017-10-01)

The Emerging Roles of the β-Secretase BACE1 and the Long Non-coding RNA BACE1-AS in Human Diseases: A Focus on Neurodegenerative Diseases and Cancer
by: Arezou Sayad, et al.
Published: (2022-03-01)

Dendrobium alkaloids decrease Aβ by regulating α- and β-secretases in hippocampal neurons of SD rats
by: Juan Huang, et al.
Published: (2019-09-01)

Extensive Structure Modification on Luteolin-Cinnamic Acid Conjugates Leading to BACE1 Inhibitors with Optimal Pharmacological Properties
by: De-Yang Sun, et al.
Published: (2019-12-01)

Soluble Gamma-secretase Modulators Attenuate Alzheimer's β-amyloid Pathology and Induce Conformational Changes in Presenilin 1
by: Frank Raven, et al.
Published: (2017-10-01)

Multifunctional Donepezil Analogues as Cholinesterase and BACE1 Inhibitors
by: Keith D. Green, et al.
Published: (2018-12-01)

Dysregulated APP expression and α-secretase processing of APP is involved in manganese-induced cognitive impairment
by: Yiping Yang, et al.
Published: (2021-09-01)

Nutrient niche specificity for glycosaminoglycans is reflected in polysaccharide utilization locus architecture of gut Bacteroides species
by: Annelieke Overbeeke, et al.
Published: (2022-11-01)

Partial reduction of amyloid β production by β-secretase inhibitors does not decrease synaptic transmission
by: Tugce Munise Satir, et al.
Published: (2020-05-01)

Calsyntenin-1 shelters APP from proteolytic processing during anterograde axonal transport
by: Martin Steuble, et al.
Published: (2012-06-01)

Gastroprotective Effects of Oral Glycosaminoglycans with Sodium Alginate in an Indomethacin-Induced Gastric Injury Model in Rats
by: Sara Traserra, et al.
Published: (2023-11-01)

BACE1-Dependent Neuregulin-1 Signaling: An Implication for Schizophrenia
by: Zhengrong Zhang, et al.
Published: (2017-09-01)

Conserved “PAL” sequence in presenilins is essential for γ-secretase activity, but not required for formation or stabilization of γ-secretase complexes
by: Jun Wang, et al.
Published: (2004-04-01)

Cell Surface Glycosaminoglycans as Receptors for Adhesion of Candida spp. to Corneal Cells
by: Ordiales Helena, et al.
Published: (2022-03-01)

Expression analysis of beta-secretase 1 (BACE1) enzyme in peripheral blood of patients with Alzheimer\'s disease
by: Alireza Vakilian, et al.
Published: (2019-06-01)

The β-Secretase 1 Enzyme as a Novel Therapeutic Target for Prostate Cancer
by: Hilal A. Rather, et al.
Published: (2023-12-01)

Highlights in BACE1 Inhibitors for Alzheimer's Disease Treatment
by: Judite R. M. Coimbra, et al.
Published: (2018-05-01)

PTPRD and DCC Are Novel BACE1 Substrates Differentially Expressed in Alzheimer’s Disease: A Data Mining and Bioinformatics Study
by: Hannah A. Taylor, et al.
Published: (2022-04-01)

Tools for the Quality Control of Pharmaceutical Heparin
by: Anthony Devlin, et al.
Published: (2019-09-01)

Reactivating the extracellular matrix synthesis of sulfated glycosaminoglycans and proteoglycans to improve the human skin aspect and its mechanical properties
by: Chajra H, et al.
Published: (2016-12-01)

Glycosaminoglycan-Based Cryogels as Scaffolds for Cell Cultivation and Tissue Regeneration
by: Annika Wartenberg, et al.
Published: (2021-09-01)

Endosome and Lysosome Membrane Properties Functionally Link to γ-Secretase in Live/Intact Cells
by: Mei C. Q. Houser, et al.
Published: (2023-02-01)

The Sea as a Rich Source of Structurally Unique Glycosaminoglycans and Mimetics
by: Ariana A. Vasconcelos, et al.
Published: (2017-08-01)